Geri
NovaBay Pharmaceuticals Inc (NBY) Fiyatı
NBY Hisse Senedi Fiyat Grafiği
NBY Kazanmak
NovaBay Pharmaceuticals Inc
$14.77
16.39%
$2.08
Kapanışta: Jan 16, 16:00:00 GMT-5
$12.91
-12.59%
$-1.85
Sonrası Piyasa: Jan 16, 20:00:00 GMT-5
Önemli İstatistikler
Önceki Kapanış
$12.69
Açılış fiyatı
$12.3
Günün Aralığı
$11.91 - $18.4
52 haftalık aralık
$0.46 - $19.95
İşlem hacmi
2.7M
Ort.Hacim
1.2M
EPS (TTM)
-6.62
Dividend yield
--
Piyasa Değeri
$1.6B
NBY nedir?
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved